Hydroxychloroquine Sulfate Tablet
Brand names: Hydroxychloroquine Sulfate
Category: Anti-Infective, Other, Rheumatology
FDA status: To Be Discontinued · Last FDA update: Jan 5, 2026 · First posted: Jan 5, 2026 · 1 manufacturers, 1 listed presentations
As of Jan 5, 2026, the FDA lists Hydroxychloroquine Sulfate Tablet as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Hydroxychloroquine Sulfate, Tablet, 200 mg (NDC 0093-2401-01) NDC 0093-2401-01 |
Teva Pharmaceuticals USA, Inc. | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Anti-Infective, Other, Rheumatology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Hydroxychloroquine Sulfate Tablet (FDA data as of Jan 5, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Hydroxychloroquine Sulfate Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/hydroxychloroquine-sulfate-tablet.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).